Sunday, June 21, 2020 1:20:58 PM
IN THE SENATE OF THE UNITED STATES
A BILL
To authorize funding for a bilateral cooperative program
with Israel for the development of health technologies
with a focus on combating COVID-19.
1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,
3 SECTION 1. SHORT TITLE.
4 This Act may be cited as the ‘‘Expanding Medical
5 Partnerships with Israel to Lessen Dependence on China
6 Act’’ or the ‘‘EMPIL-DOC Act’’.
7 SEC. 2. BILATERAL COOPERATIVE AGREEMENT.
8 (a) AUTHORIZATION OF APPROPRIATIONS.—There is
9 authorized to be appropriated to the Secretary of Health
https://www.cruz.senate.gov/files/documents/Bills/2020.04.16%20-%20Expanding%20Medical%20Partnerships%20with%20Israel%20to%20Lessen%20Dependence%20on%20China%20Act.pdf
Jun 8, 2020
The American Israel Public Affairs Committee (AIPAC) is making significant headway in lobbying Congress to pass a new bill that would deepen coronavirus cooperation with Israel while pushing China out of the way.
https://www.al-monitor.com/pulse/originals/2020/06/aipac-lobby-us-israel-coronavirus-bill-counter-china.html
A BILL
To authorize funding for a bilateral cooperative program
with Israel for the development of health technologies
with a focus on combating COVID-19.
1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,
3 SECTION 1. SHORT TITLE.
4 This Act may be cited as the ‘‘Expanding Medical
5 Partnerships with Israel to Lessen Dependence on China
6 Act’’ or the ‘‘EMPIL-DOC Act’’.
7 SEC. 2. BILATERAL COOPERATIVE AGREEMENT.
8 (a) AUTHORIZATION OF APPROPRIATIONS.—There is
9 authorized to be appropriated to the Secretary of Health
https://www.cruz.senate.gov/files/documents/Bills/2020.04.16%20-%20Expanding%20Medical%20Partnerships%20with%20Israel%20to%20Lessen%20Dependence%20on%20China%20Act.pdf
Jun 8, 2020
The American Israel Public Affairs Committee (AIPAC) is making significant headway in lobbying Congress to pass a new bill that would deepen coronavirus cooperation with Israel while pushing China out of the way.
https://www.al-monitor.com/pulse/originals/2020/06/aipac-lobby-us-israel-coronavirus-bill-counter-china.html
Recent DYAI News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2026 01:11:20 PM
- Dyadic and Scripps Research Collaborate on Rapid-Response Hantavirus Antibody and Vaccine Development • GlobeNewswire Inc. • 05/28/2026 11:25:00 AM
- Dyadic to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026 • GlobeNewswire Inc. • 05/21/2026 08:05:00 PM
- Sidoti Events, LLC's May Micro-Cap Virtual Conference • ACCESS Newswire • 05/20/2026 11:30:00 AM
- Dyadic Applied BioSolutions Announces Participation in Sidoti Virtual Investor Conference • GlobeNewswire Inc. • 05/19/2026 01:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 08:11:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 08:10:46 PM
- Dyadic Announces First Quarter 2026 Financial Results and Highlights Recent Company Progress • GlobeNewswire Inc. • 05/13/2026 08:05:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/12/2026 08:30:27 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/11/2026 08:42:09 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/01/2026 09:00:51 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/30/2026 08:00:46 PM
- Dyadic to Report Q1 2026 Financial Results and Host Conference Call on Wednesday May 13, 2026 • GlobeNewswire Inc. • 04/29/2026 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/28/2026 01:56:17 AM
- Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress • GlobeNewswire Inc. • 03/25/2026 08:51:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:14:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/25/2026 08:13:15 PM
- Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices • GlobeNewswire Inc. • 03/16/2026 11:20:00 AM
- Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 03/13/2026 12:35:00 PM
- Dyadic to Report 2025 Full Year Financial Results and Host Conference Call on Wednesday, March 25, 2026 • GlobeNewswire Inc. • 03/11/2026 08:10:00 PM
- Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th • GlobeNewswire Inc. • 03/10/2026 02:21:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2026 10:04:30 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/06/2026 10:02:34 PM
- Dyadic and Fermbox Bio Launch First Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free) • GlobeNewswire Inc. • 03/04/2026 12:20:00 PM
